Form 4: Northwest Biotherapeutics Executive Reports Gift of Stock Options

Alton L. Boynton, Chief Scientific Officer of Northwest Biotherapeutics, reports gifting 1,000,000 stock options to family members for estate planning purposes.

Summary

• Alton L. Boynton, the Chief Scientific Officer of Northwest Biotherapeutics Inc., filed a Form 4 with the SEC on September 3, 2024.
• The form reports a transaction that occurred on August 29, 2024, where Boynton gifted 1,000,000 stock options to family members.
• These options have an exercise price of $0.23 and expire on August 31, 2028.
• The underlying security is common stock with a par value of $0.001.
• Following the transaction, Boynton directly owns 967,065 shares.
• The gift was made for estate planning purposes to family members who do not share the same residence.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing regarding an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it involves the transfer of stock options, but it's primarily for estate planning purposes.

Key Dates